FilingSEC EDGAR8-K
IRulya Therapeutics Announces Name Change and Leadership Transition
· SEC accepted
StageLeadership Transition
Filing content
Quince Therapeutics has changed its name to IRulya Therapeutics and appointed new CEO and CFO. The company will focus on the development of LAM-001.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…